+919405117673
Lamivudine + Zidovudine 30mg/60mg Tablets Manufacturer & Exporter from India Cordium Pharmaceuticals
Cordium Pharmaceuticals Pvt. Ltd. is a reliable pharmaceutical manufacturer and exporter of Lamivudine + Zidovudine 30mg/60mg Tablets, serving international buyers across the USA, UK, UAE, South Africa, Singapore, Australia, Canada, Germany, and other regulated and semi-regulated markets.

Lamivudine + Zidovudine is a fixed-dose combination of two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) indicated for use as part of combination antiretroviral therapy (ART) for the treatment of HIV infection. This pediatric-strength dosage is commonly used according to physician recommendations and national HIV treatment programs.

Product Specifications
Product Name: Lamivudine + Zidovudine Tablets
Strength: 30mg + 60mg
Dosage Form: Film-Coated Tablets
Therapeutic Category: Antiretroviral (NRTI Combination)
Indication: HIV Infection (used in combination with other antiretroviral medicines)
Packaging: Custom export packaging available
Manufacturer: Cordium Pharmaceuticals Pvt. Ltd.
Country of Origin: India
Global Export Markets

Cordium Pharmaceuticals supplies Lamivudine + Zidovudine 30mg/60mg tablets to international distributors, government procurement agencies, hospitals, NGOs, and healthcare organizations in:

USA
United Kingdom (UK)
United Arab Emirates (UAE)
South Africa
Singapore
Australia
Canada
Germany

We also export to Africa, Southeast Asia, Latin America, CIS countries, and other global destinations.

Why Lamivudine + Zidovudine?

Lamivudine and Zidovudine work by inhibiting HIV reverse transcriptase, helping reduce viral replication when used with other antiretroviral medicines. Fixed-dose combinations help simplify treatment regimens and support adherence. Current HIV treatment guidelines in many countries often prioritize newer regimens for many patients, but this combination continues to have specific clinical and pediatric uses in certain settings.

Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
Experienced pharmaceutical exporter from India
International-quality manufacturing standards
Reliable bulk supply capabilities
Competitive pricing for global procurement
Professional export documentation
Timely worldwide delivery
Private labeling and third-party manufacturing support
Dedicated customer support for international buyers
Industries We Serve
Pharmaceutical Importers
Government Healthcare Programs
HIV/AIDS Treatment Centers
NGOs
Hospital Supply Chains
Medical Distributors
International Tender Suppliers
Frequently Asked Questions (FAQs)
1. What is Lamivudine + Zidovudine 30mg/60mg used for?

It is an antiretroviral medicine used in combination with other HIV medicines for the treatment of HIV infection, particularly in pediatric treatment settings according to medical guidelines.

2. Does Cordium Pharmaceuticals export internationally?

Yes. We export pharmaceutical products to the USA, UK, UAE, South Africa, Singapore, Australia, Canada, Germany, and many other international markets.

3. Is private labeling available?

Yes. We provide OEM manufacturing and private labeling services for eligible international clients.

4. Can distributors place bulk orders?

Yes. We welcome inquiries from wholesalers, distributors, government agencies, NGOs, hospitals, and pharmaceutical importers.

5. What documents are provided for export?

Depending on destination-country requirements, we can provide export documentation such as Certificate of Analysis (COA), Certificate of Pharmaceutical Product (CPP, where applicable), Product Dossier, MSDS (if applicable), and other regulatory documents.
Partner with Cordium Pharmaceuticals

If you are looking for a dependable Lamivudine + Zidovudine 30mg/60mg manufacturer and exporter from India, Cordium Pharmaceuticals Pvt. Ltd. is committed to delivering high-quality pharmaceutical products, competitive pricing, reliable logistics, and responsive customer support for global healthcare partners.

Contact us today to discuss bulk orders, distribution partnerships, contract manufacturing, or private-label opportunities.
Jul 15th, 2026 4:02 PM

Keywords